These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6073464)

  • 21. [Basic and clinical studies of pancuronium bromide].
    Miyashita K; Kobayashi T; Fukushima K
    Masui; 1971 Jul; 20(7):655-64. PubMed ID: 4254460
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of some cardiovascular effects of tubocurarine and pancuronium in dogs.
    Smith G; Proctor DW; Spence AA
    Br J Anaesth; 1970 Nov; 42(11):923-7. PubMed ID: 4249791
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man.
    Katz RL; Gissen AJ
    Anesthesiology; 1967; 28(3):564-7. PubMed ID: 4225766
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental and clinical studies on pancuronium bromide].
    Honjo S; Kamiyama M; Shimizu R; Okada K; Yamamura H
    Masui; 1971 Apr; 20(4):314-9. PubMed ID: 4255690
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of pancuronium bromide on the motor nerve terminal.
    Dretchen KL; Sokoll MD; Gergis SD; Long JP
    Eur J Pharmacol; 1972 Oct; 20(1):46-51. PubMed ID: 4264266
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.
    Buckett WR; Marjoribanks CE; Marwick FA; Morton MB
    Br J Pharmacol Chemother; 1968 Mar; 32(3):671-82. PubMed ID: 4171017
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of muscle relaxing agents, pancuronium bromide, d-tubocurarine chloride, on human adrenocotrical function].
    Matsuki A; Kudo T; Oyama C
    Horumon To Rinsho; 1971 Jul; 19(7):543-7. PubMed ID: 4255689
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical comparison of pancuronium with d-tubocurarine.
    McDowell SA; Clarke RS
    Anaesthesia; 1969 Oct; 24(4):581-90. PubMed ID: 4187021
    [No Abstract]   [Full Text] [Related]  

  • 29. The neuromuscular blocking actions of pancuronium.
    Norman J; Katz RL; Seed RF
    Anaesthesia; 1970 Jan; 25(1):130. PubMed ID: 4244174
    [No Abstract]   [Full Text] [Related]  

  • 30. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 31. A new non-depolarizing myorelaxant with high activity and specificity.
    Cherepanova VP; Danilov AF; Khromov-Borisov NV; Malygin VV; Starshinova LA; Torf SF
    Eur J Pharmacol; 1982 Jul; 81(2):245-54. PubMed ID: 6288406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuromuscular blocking action of pancuronium in man during anaesthesia.
    Norman J; Katz RL; Seed RF
    Br J Anaesth; 1970 Aug; 42(8):702-10. PubMed ID: 4249574
    [No Abstract]   [Full Text] [Related]  

  • 33. Further clinical studies on pancuronium bromide. 2. A study of the effects on the blood pressure and pulse rate.
    Komesaroff D
    Med J Aust; 1970 Sep; 2(11):497-9. PubMed ID: 5477802
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of some adrenergic beta-receptor antagonists on the act ion of d-tubocurarine and pancuronium bromide.
    Saini RK; Sharma PL
    Indian J Med Res; 1971 Jul; 59(7):1104-8. PubMed ID: 4144427
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.
    Krieg N; Crul JF; Booij LH
    Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ganglion blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat.
    Marshall IG
    J Pharm Pharmacol; 1973 Jul; 25(7):530-6. PubMed ID: 4147049
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancuronium bromide (Pavulon) evaluation of its clinical pharmacology.
    Dobkin AB; Evers W; Ghanooni S; Levy AA; Thomas ET
    Can Anaesth Soc J; 1971 Sep; 18(5):512-35. PubMed ID: 5094102
    [No Abstract]   [Full Text] [Related]  

  • 38. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological interaction between pancuronium bromide and anaesthetics.
    Bonta IL; Goorissen EM; Derkx FH
    Eur J Pharmacol; 1968 Aug; 4(1):83-90. PubMed ID: 5680373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study between pancuronium bromide and d-tubocurarine].
    Costa PN
    Rev Bras Anestesiol; 1971; 21(4):721-7. PubMed ID: 4259786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.